| VEGF | Vascular endothelial growth factor |
| VEGFR-1/2 | Vascular Endothelial Growth Factor Receptors 1 and 2 |
| PDGF | Platelet-derived growth factor |
| PDGF-A/B/C/D | PDGF isoforms |
| TGF-β | Transforming growth factor-beta |
| IGF-1/2 | Insulin-like growth factor-1/2 |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| FGF | Fibroblast growth factor |
| FGFR | Fibroblast growth factor receptor |
| MMPs | Matrix metalloproteinases |
| TIMPs | Tissue inhibitors of metalloproteinases |
| TNF-α | Tumor necrosis factor-alpha |
| IL-6, IL-1β | Interleukin-6, Interleukin-1 beta |
| PLCγ | Phospholipase C-gamma |
| PKC | Protein kinase C |
| Raf | Rapidly accelerated fibrosarcoma kinase |
| MEK | Mitogen-activated protein kinase kinase |
| MAPK | Mitogen-activated protein kinase |
| TbRI | Transforming growth factor-β receptor type I |
| PP2C | Protein phosphatase 2C |
| mTOR | Mechanistic target of rapamycin |